AKAN Stock — Akanda Corp.

Akanda Corp. (AKAN)

Updated October 16, 2026.

AKAN is a Stock. Its deepest 1-year drawdown was 97.9%.

Akanda Corp. is an early-stage cannabis company based in Toronto that cultivates, manufactures, and sells medical cannabis in Mexico, while also operating a telecommunications infrastructure business leasing fiber optic networks and telecommunication towers. The company does not currently have an established distribution schedule. This security may appeal to investors seeking exposure to the cannabis industry, though as an early-stage enterprise it carries characteristic risks of companies in development phases.

AKAN performance

Returns are updating. AKAN's total return appears here after the next nightly update.

Its deepest 1-year drawdown was 97.9%.

AKAN key facts

Asset type

Stock

Asset class

Equity

Inception date

03/15/2022

Distribution frequency

None

Last close

$1.20 (as of 2026-10-16)

Market cap

$2,865,854

Average volume

137040.0

Payout ratio

0.0%

EPS

$-14,935.32

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

AKAN risks and drawbacks

The deepest 1-year drawdown on record here is 97.9%.

Who may consider AKAN — and who may not

It is a weaker fit for investors who need monthly cash flow (AKAN does not currently distribute). This is educational context, not a recommendation to buy or sell.

More on AKAN

• All tickers starting with A

Tagged: Pharmaceutical.

Frequently asked questions